Table 2.
Health-related quality of life between patients with inflammatory bowel diseases and healthy controls.
| Characteristics | IBD patients (n = 209) | Controls (n = 209) | P |
|---|---|---|---|
| SIBDQ (mean ± SD)a | 55.0 ± 13.6 | 63.0 ± 5.0 | <.01 |
| HADS-anxiety (mean ± SD)b | 4.0 ± 4.0 | 3.4 ± 2.5 | .04 |
| HADS-depression (mean ± SD)b | 3.4 ± 3.1 | 2.3 ± 2.3 | <.01 |
| FACIT-Fatigue (mean± SD)a | 40.9 ± 8.5 | 45.6 ± 4.3 | <.01 |
| Work productivity impairment %(mean± SD)b | 17.8 ± 25.3 | 6.8 ± 10.9 | <.01 |
| EQ5D5L-TTO (mean± SD)a | 0.913 ± 0.167 | 0.963 ± 0.056 | <.01 |
| EQ5D5L-VAS (mean± SD)a | 77.9 ± 16.2 | 88.0 ± 8.8 | <.01 |
Abbreviations: SIBDQ: Short Inflammatory Bowel Disease Questionnaire; FACIT-F: Functional Assessment of Chronic Illness Therapy-Fatigue; Percentage of Work Productivity Impairment questionnaire; EQ5D5L-TTO and VAS: European Quality of Life 5-Dimensions 3-Level; time-trade-off and visual analog scale; HADS: Hospital Anxiety and Depression Scale.
Higher values for SIBDQ, FACIT-F, EQ5D5L scores indicate good quality of life.
Higher values for WPAI, HADS scores indicate poor quality of life.